Clinical trial
Phase I Randomized Study of CPX for the Treatment of Adult Patients With Mild…
NCT00004428 · FDA Office of Orphan Products Development, U.S. Fed · Completed
Key facts
| NCT number | NCT00004428 |
|---|---|
| Title | Phase I Randomized Study of CPX for the Treatment of Adult Patients With Mild Cystic Fibrosis |
| Lead sponsor | FDA Office of Orphan Products Development, U.S. Fed |
| Collaborators | SciClone Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug |
| Interventions | CPX |
| Enrollment | 35 |
| Start date | Sep 1, 1997 |
| Completion | Oct 1, 1999 |
| First posted | Oct 19, 1999 |
| Last update posted | Mar 25, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: